APA

Helliwell P. S., Gladman D. D., Chakravarty S. D., Kafka S., Karyekar C. S., You Y., Campbell K., Sweet K., Kavanaugh A. & Gensler L. S. (20210419). Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials. : RMD open.

Chicago

Helliwell Philip S, Gladman Dafna D, Chakravarty Soumya D, Kafka Shelly, Karyekar Chetan S, You Yin, Campbell Kim, Sweet Kristen, Kavanaugh Arthur and Gensler Lianne S. 20210419. Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials. : RMD open.

Harvard

Helliwell P. S., Gladman D. D., Chakravarty S. D., Kafka S., Karyekar C. S., You Y., Campbell K., Sweet K., Kavanaugh A. and Gensler L. S. (20210419). Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials. : RMD open.

MLA

Helliwell Philip S, Gladman Dafna D, Chakravarty Soumya D, Kafka Shelly, Karyekar Chetan S, You Yin, Campbell Kim, Sweet Kristen, Kavanaugh Arthur and Gensler Lianne S. Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials. : RMD open. 20210419.